Trial Profile
A Phase 1 Study of Weekly Doses of GCS-100 in Patients With Chronic Kidney Disease
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs GCS 100 (Primary)
- Indications Kidney disorders
- Focus Adverse reactions
- Sponsors La Jolla Pharmaceutical Company
- 18 May 2014 New trial record